p53 as a biomarker and potential target in gastrointestinal stromal tumors.

Wu, Chiao-En; Chen, Chiao-Ping; Huang, Wen-Kuan; Pan, Yi-Ru; Aptullahoglu, Erhan; Yeh, Chun-Nan; Lunec, John

Wu, Chiao-En; Chen, Chiao-Ping; Huang, Wen-Kuan; Pan, Yi-Ru; Aptullahoglu, Erhan; Yeh, Chun-Nan; Lunec, John.

Affiliation

Wu CE; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Chen CP; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Huang WK; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Pan YR; Department of General Surgery and Liver Research Center, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan, Taiwan.
Aptullahoglu E; Department of Molecular Biology and Genetics, Bilecik Seyh Edebali University, Bilecik, Turkey.
Yeh CN; Department of General Surgery and Liver Research Center, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan, Taiwan.
Lunec J; Newcastle University Cancer Center, Bioscience Institute, Medical Faculty, Newcastle University, Newcastle upon Tyne, United Kingdom.

Front Oncol ; 12: 872202, 2022.

Article de En | MEDLINE | ID: mdl-35965531

Mots clés

MDM2; Wee1; gastrointestinal stromal tumors (GIST); p53; target therapy

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Front Oncol Année: 2022 Type de document: Article Pays d'affiliation: Taïwan

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google